A proposed prescription drug price cap will lead to reductions in R&D spending and could have a negative knock-on effect for CROs say experts.
Recipharm will cut jobs to reduce costs after lower customer demand.
Trilantic Capital Partners Europe has bought a majority stake in Doppel Farmaceutici, citing the growth potential of Europe’s contracting market as the driver.
US compounder Pharmedium has recalled sterile drugs made with contaminated saline supplied by Pfizer's Hospira unit.
The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.